California, Texas, Oklahoma Advance 340B Contract Pharmacy Access Bills with Key Amendments

California lawmakers recently advanced a 340B contract pharmacy access bill through committee but amended it to exclude 340B hospitals.
State legislators in California, Texas and Oklahoma have recently advanced 340B contract pharmacy access bills with amendments that in some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in Early 2025, Filings Show

Just over 300 firms listed the 340B program in their first quarter lobbying disclosure forms that were due April 21.
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Appellate Court Briefings on 340B Laws in West Virginia, Louisiana

Key briefs were filed recently in state contract pharmacy litigation in two federal appeals court.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Trump Pharmaceutical Tariffs Loom, Drug Industry Pledges Investment in U.S. Manufacturing, Warns of Disruptions 

A recent survey of biotechnology firms reported that Trump's planned pharmaceutical tariffs would set back scientific innovation and reduce patients' access to medications.
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Continues to Oppose Unapproved Drugmaker 340B Rebate Models in New Legal Filings

HHS has again urged a federal district court to reject multiple drug industry lawsuits seeking to implement 340B rebate models.
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Sues Utah Over New 340B Contract Pharmacy Access Law

A drug industry trade group recently challenged Utah's new 340B contract pharmacy access law in the U.S. District Court for the District of Utah.
An influential drug industry trade group on Friday sued Utah over its 340B contract pharmacy access law, marking the third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals, Health Centers Criticize Trump’s Executive Order Over Controversial 340B Rule, Possible Medicare Payment Cuts

President Donald Trump (R) issued a wide-ranging April 15 executive order on drug pricing policy.
Hospital and health center leaders are pushing back against President Donald Trump’s (R) new executive order, criticizing its controversial 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck Exempts Three More States from 340B Restrictions, Novartis Sues Utah Over Contract Pharmacy Access Law

Merck recently announced it would exempt additional states from its 340B contract pharmacy restrictions.
Merck is lifting its 340B contract pharmacy restrictions in three more states that have recently enacted contract pharmacy access laws—while [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live